NCT04870008

Brief Summary

It is standard teaching that the top layer of sutures should be placed 3-5mm from the wound edge. However, there is lack of data regarding the most optimal placement of sutures from the wound edge for the best cosmetic outcome. The research team wish to determine if sutures placed closer to the wound edge (2mm) or farther from the wound edge (5mm) makes a difference in the cosmetic outcome of the scar.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 20, 2019

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 20, 2020

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2021

Completed
27 days until next milestone

First Submitted

Initial submission to the registry

April 28, 2021

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 3, 2021

Completed
Last Updated

May 3, 2021

Status Verified

April 1, 2021

Enrollment Period

1 year

First QC Date

April 28, 2021

Last Update Submit

April 30, 2021

Conditions

Outcome Measures

Primary Outcomes (2)

  • The score of two blinded reviewers using the patient observer scar assessment score

    At the follow-up visit, two blinded observers will record their scores independently using the POSAS (Patient and Observer Scar Assessment Scale) instrument. Each item of the POSAS is rated on a 10-point score. The lowest score is '1', which corresponds to the situation of normal skin (i.e. normal pigmentation, no itching). Score 10 equals the largest difference from normal skin (i.e. the worst imaginable scar or sensation). The total score of both scales can be simply calculated by summing up the scores of each of the six items.

    3-12 months

  • The mean scar width using the trace-to-tape method at the assessment visit

    The trace-to-tape method is an objective outcome measure for linear postoperative scars. Mean scar width in mm.

    3-12 months

Secondary Outcomes (1)

  • Any complications from the treatment

    3-12 months

Study Arms (2)

2 mm

ACTIVE COMPARATOR

The side of patient's scar that will receive the sutures placed at 2 mm from wound edge.

Procedure: Suture

5 mm

ACTIVE COMPARATOR

The side of patient's scar that will receive the sutures placed at 5 mm from wound edge.

Procedure: Suture

Interventions

SuturePROCEDURE

The side of patient's scar that will receive the sutures placed at 2 or 5 mm from wound edge.

2 mm5 mm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age or older
  • Able to give informed consent themselves
  • Patient scheduled for cutaneous surgical procedure on the head and neck with predicted primary closure
  • Willing to return for follow up visit

You may not qualify if:

  • Mentally handicapped
  • Incarceration
  • Under 18 years of age
  • Pregnant Women
  • Wounds with predicted closure length less than 3 cm

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of California, Davis

Sacramento, California, 95816, United States

Location

MeSH Terms

Conditions

Cicatrix

Interventions

Sutures

Condition Hierarchy (Ancestors)

FibrosisPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Surgical Fixation DevicesSurgical EquipmentEquipment and Supplies

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Clinical Dermatology, Director of Dermatologic Surgery

Study Record Dates

First Submitted

April 28, 2021

First Posted

May 3, 2021

Study Start

November 20, 2019

Primary Completion

November 20, 2020

Study Completion

April 1, 2021

Last Updated

May 3, 2021

Record last verified: 2021-04

Locations